Advances in electrochemical detection for study of neurodegenerative disorders

Analytical and Bioanalytical Chemistry

Volumn 405, Issue 17, 2013, Pages 5725-5741

  Veloso, Anthony ^a   Kerman, Kagan ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Amyloid aggregation; Electrochemical; Impedance spectroscopy; Peak H; Prion; Tyrosine oxidation

Indexed keywords

ELECTROCHEMICAL; IMPEDANCE SPECTROSCOPY; PEAK H; PRION; TYROSINE OXIDATION;

AGGREGATES; AMINO ACIDS; ATOMIC FORCE MICROSCOPY; CIRCULAR DICHROISM SPECTROSCOPY; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; ELECTROCHEMISTRY; GLYCOPROTEINS; NEURODEGENERATIVE DISEASES; SPECTROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

PROTEINS;

DIAGNOSTIC AGENT; PROTEIN;

CHEMISTRY; DEGENERATIVE DISEASE; ELECTROCHEMICAL ANALYSIS; HUMAN; METABOLISM; METHODOLOGY; REVIEW;

ELECTROCHEMICAL TECHNIQUES; HUMANS; NEURODEGENERATIVE DISEASES; PROTEINS;

EID: 84879837040     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-013-6904-3     Document Type: Review

References (205)

1. Aguzzi A, Calella AM (2009) Prions: Protein aggregation and infectious diseases. Physiol Rev 89:1105-1152
2. Rountree JSS, Butters TD, Wormald MR, Boomkamp SD, Dwek RA, Asano N, Ikeda K, Evinson EL, Nash RJ, Fleet GWJ (2009) Design, synthesis and biological evaluation of enantiomeric beta-n-acetylhexosaminidase inhibitors LABNAc and DABNAc as potential agents against Tay-Sachs and Sandhoff disease. Chem Med Chem 4:378-392
3. Muoio DM, Newgard CB (2008) Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nature Rev Mol Cell Biol 9:193-205
4. Luciani A, Villella VR, Esposito S, Brunetti-Pierri N, Medina D, Settembre C, Gavina M, Pulze L, Giardino I, Pettoello-Mantovani M, D'Apolito M, Guido S, Masliah E, Spencer B, Quaratino S, Raia V, Ballabio A, Maiuri L (2010) Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition. Nature Cell Biology 12:863-875
5. Dobson CM (1999) Protein misfolding, evolution and disease. Trends Biochem Sci 24:329-332
6. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA (2003) Alzheimer disease in the US population - Prevalence estimates using the 2000 census. Arch Neurol 60:1119-1122
7. Hindle JV (2010) Ageing, neurodegeneration and Parkinson's disease. Age Ageing 39:156-161
8. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, PericakVance MA, Risch N, vanDuijn CM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease - A meta-analysis. J Am Med Assoc 278:1349-1356
9. Rising Tide: The impact of dementia on Canadian society (2012) Alzheimer's Society of Canada, Toronto. www.alzheimer.ca/. Accessed 1 Dec 2012
10. Yin F, Liu J, Ji X, Wang Y, Zidichouski J, Zhang J (2011) Baicalin prevents the production of hydrogen peroxide and oxidative stress induced by A beta aggregation in SH-SY5Y cells. Neurosci Lett 492:76-79
11. Bieschke J, Russ J, Friedrich RP, Ehrnhoefer DE, Wobst H, Neugebauer K, Wanker EE (2010) EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity. Proc Natl Acad Sci USA 107:7710-7715
12. Ehrnhoefer DE, Bieschke J, Boeddrich A, Herbst M, Masino L, Lurz R, Engemann S, Pastore A, Wanker EE (2008) EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol 15:558-566
13. Grelle G, Otto A, Lorenz M, Frank RF, Wanker EE, Bieschke J (2011) Black tea theaflavins inhibit formation of toxic amyloid-beta and alpha-synuclein fibrils. Biochemistry 50:10624-10636
14. Piazzi L, Cavalli A, Colizzi F, Belluti F, Bartolini M, Mancini F, Recanatini M, Andrisano V, Rampa A (2008) Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds. Bioorg Med Chem Lett 18:423-426
15. Rizzo S, Bartolini M, Ceccarini L, Piazzi L, Gobbi S, Cavalli A, Recanatini M, Andrisano V, Rampa A (2010) Targeting Alzheimer's disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238. Bioorg Med Chem 18:1749-1760
16. Bolognesi ML, Bartolini M, Tarozzi A, Morroni F, Lizzi F, Milelli A, Minarini A, Rosini M, Hrelia P, Andrisano V, Melchiorre C (2011) Multitargeted drugs discovery: Balancing anti-amyloid and anticholinesterase capacity in a single chemical entity. Bioorg Med Chem Lett 21:2655-2658
17. Bush AI (2008) Drug development based on the metals hypothesis of Alzheimer's disease. J Alz Dis 15:223-240
18. Hindo SS, Mancino AM, Braymer JJ, Liu Y, Vivekanandan S, Ramamoorthy A, Lim MH (2009) Small molecule modulators of copper-induced A beta aggregation. J Am Chem Soc 131:16663-16665
19. Mancino AM, Hindo SS, Kochi A, Lim MH (2009) Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited. Inorg Chem 48:9596-9598
20. Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75:333-366
21. Cohen AS (1967) Amyloidosis. New Engl J Med 277:522-530
22. Elghetany MT, Saleem A (1988) Methods for staining amyloid in tissues - A review. Stain Technol 63:201-212
23. Butovsky O, Talpalar AE, Ben-Yaakov K, Schwartz M (2005) Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective. Mol Cell Neurosci 29:381-393
24. Bolognesi B, Kumita JR, Barros TP, Esbjorner EK, Luheshi LM, Crowther DC, Wilson MR, Dobson CM, Favrin G, Yerbury JJ (2010) ANS binding reveals common features of cytotoxic amyloid species. ACS Chem Biol 5:735-740
25. Almeida MR, Saraiva MJ (2012) Clearance of extracellular misfolded proteins in systemic amyloidosis: Experience with transthyretin. FEBS Lett 586:2891-2896
26. Glabe CG (2006) Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol Aging 27:570-575
27. Glabe CG, Kayed R (2006) Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis. Neurology 66:S74-S78
28. Kayed R, Glabe CG (2006) Conformation-dependent anti-amyloid oligomer antibodies. Methods Enzymol 413:326-344
29. Walsh DM, Lomakin A, Benedek GB, Condron MM, Teplow DB (1997) Amyloid beta-protein fibrillogenesis - Detection of a protofibrillar intermediate. J Biol Chem 272:22364-22372
30. Querfurth HW, LaFerla FM (2010) Mechanisms of disease: Alzheimer's disease. New Engl J Med 362:329-344
31. Jarrett JT, Berger EP, Lansbury PT (1993) The c-terminus of the beta-protein is critical in amyloidogenesis. In: Nitsch RM, Growdon JH, Corkin S, Wurtman RJ (eds) Alzheimers Disease: Amyloid Precusor Proteins, Signal Transduction, and Neuronal Transplantation. New York Academy of Sciences, New York
32. Dickson DW, Lee SC, Mattiace LA, Yen SHC, Brosnan C (1993) Microglia and cytokines in neurological disease with special reference to aids and Alzheimer's disease. Glia 7:75-83
33. Meda L, Cassatella MA, Szendrei GI, Otvos L, Baron P, Villalba M, Ferrari D, Rossi F (1995) Activation of microglia cells by beta-amyloid protein and interferon-gamma. Nature 374:647-650
34. Mosharov EV, Larsen KE, Kanter E, Phillips KA, Wilson K, Schmitz Y, Krantz DE, Kobayashi K, Edwards RH, Sulzer D (2009) Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. Neuron 62:218-229
35. Parkinson J (2002) An essay on the shaking palsy. J Neuropsych Clin N 14:223-236
36. Maroteaux L, Campanelli JT, Scheller RH (1988) Synuclein - A neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8:2804-2815
37. Clinton LK, Blurton-Jones M, Myczek K, Trojanowski JQ, LaFerla FM (2010) Synergistic interactions between a beta, tau, and alpha-synuclein: Acceleration of neuropathology and cognitive decline. J Neurosci 30:7281-7289
38. Duka T, Rusnak M, Drolet RE, Duka V, Wersinger C, Goudreau JL, Sidhu A (2006) Alpha-synuclein induces hyperphosphorylation of tau in the MPTP model of Parkinsonism. FASEB J 20:2302-2312
39. Badiola N, de Oliveira RM, Herrera F, Guardia-Laguarta C, Goncalves SA, Pera M, Suarez-Calvet M, Clarimon J, Outeiro TF, Lleo A (2011) Tau enhances alpha-synuclein aggregation and toxicity in cellular models of synucleinopathy. PLoS One. doi: 10.1371/journal.pone.0026609
40. Jellinger KA (2011) Interaction between alpha-synuclein and other proteins in neurodegenerative disorders. Scientific World Journal 11:1893-1907
41. Paulson HL, Bonini NM, Roth KA (2000) Polyglutamine disease and neuronal cell death. Proc Natl Acad Sci USA 97:12957-12958
42. Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H, Wanker EE, Bates GP, Housman DE, Thompson LM (2000) The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci USA 97:6763-6768
43. Difiglia M, Sapp E, Chase K, Schwarz C, Meloni A, Young C, Martin E, Vonsattel JP, Carraway R, Reeves SA, Boyce FM, Aronin N (1995) Huntingtin is a cytoplasmic protein associated with vesicles in human and rat-brain neurons. Neuron 14:1075-1081
44. Gusella JF, Macdonald ME (1995) Huntington's disease. Semin Cell Biol 6:21-28
45. Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90:537-548
46. Atarashi R, Moore RA, Sim VL, Hughson AG, Dorward DW, Onwubiko HA, Priola SA, Caughey B (2007) Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat Methods 4:645-650
47. Soto C, Castilla J (2004) The controversial protein-only hypothesis of prion propagation. Nat Med 10:S63-S67
48. Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216:136-144
49. Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, Caughey B (2005) The most infectious prion protein particles. Nature 437:257-261
50. Pauly PC, Harris DA (1998) Copper stimulates endocytosis of the prion protein. J Biol Chem 273:33107-33110
51. Soto C, Estrada LD (2008) Protein misfolding and neurodegeneration. Arch Neurol 65:184-189
52. Collins SR, Douglass A, Vale RD, Weissman JS (2004) Mechanism of prion propagation: Amyloid growth occurs by monomer addition. PLoS Biol 2:1582-1590
53. Knowles TPJ, Waudby CA, Devlin GL, Cohen SIA, Aguzzi A, Vendruscolo M, Terentjev EM, Welland ME, Dobson CM (2009) An analytical solution to the kinetics of breakable filament assembly. Science 326:1533-1537
54. Xue WF, Homans SW, Radford SE (2008) Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assembly. Proc Natl Acad Sci USA 105:8926-8931
55. Sukhanova A, Poly S, Shemetov A, Bronstein I, Nabiev I (2012) Implications of protein structure instability: From physiological to pathological secondary structure. Biopolymers 97:577-588
56. Ferrone F (1999) Analysis of protein aggregation kinetics. Amyloid, Prions, and Other Protein Aggregates 309:256-274
57. Sabate R, Gallardo M, Estelrich J (2003) An autocatalytic reaction, as a model for the kinetics of the aggregation of beta-amyloid. Biopolymers 71:190-195
58. Muench C, Bertolotti A (2012) Propagation of the prion phenomenon: Beyond the seeding principle. J Mol Biol 421:491-498
59. Harper JD, Lieber CM, Lansbury PT (1997) Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein. Chem Biol 4:951-959
60. Jimenez JL, Guijarro JL, Orlova E, Zurdo J, Dobson CM, Sunde M, Saibil HR (1999) Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing. EMBO J 18:815-821
61. Bhak G, Choe YJ, Paik SR (2009) Mechanism of amyloidogenesis: nucleation-dependent fibrillation versus double-concerted fibrillation. BMB Reports 42:541-551
62. Petkova AT, Buntkowsky G, Dyda F, Leapman RD, Yau WM, Tycko R (2004) Solid state NMR reveals a pH-dependent antiparallel beta-sheet registry in fibrils formed by a beta-amyloid peptide. J Mol Biol 335:247-260
63. Schmechel A, Zentgraf H, Scheuermann S, Fritz G, Pipkorn RD, Reed J, Beyreuther K, Bayer TA, Multhaup G (2003) Alzheimer beta-amyloid homodimers facilitate a beta fibrillization and the generation of conformational antibodies. J Biol Chem 278:35317-35324
64. Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, Apostol MI, Thompson MJ, Balbirnie M, Wiltzius JJW, McFarlane HT, Madsen AO, Riekel C, Eisenberg D (2007) Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 447:453-457
65. Uversky VN (2010) Mysterious oligomerization of the amyloidogenic proteins. FEBS J 277:2940-2953
66. Breydo L, Uversky VN (2011) Role of metal ions in aggregation of intrinsically disordered proteins in neurodegenerative diseases. Metallomics 3:1163-1180
67. Tougu V, Tiiman A, Palumaa P (2011) Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity. Metallomics 3:250-261
68. Smith DG, Cappai R, Barnham KJ (2007) The redox chemistry of the Alzheimer's disease amyloid beta peptide. Biochim Biophys Acta 1768:1976-1990
69. Miller LM, Wang Q, Telivala TP, Smith RJ, Lanzirotti A, Miklossy J (2006) Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease. J Struct Biol 155:30-37
70. Rajendran R, Ren M, Dolores Ynsa M, Casadesus G, Smith MA, Perry G, Halliwell B, Watt F (2009) A novel approach to the identification and quantitative elemental analysis of amyloid deposits-Insights into the pathology of Alzheimer's disease. Biochem Biophys Res Commun 382:91-95
71. Jiang D, Zhang L, Grant GPG, Dudzik CG, Chen S, Patel S, Hao Y, Millhauser GL, Zhou F (2013) The elevated copper binding strength of amyloid-beta aggregates allows the sequestration of copper from albumin: A pathway to accumulation of copper in senile plaques. Biochemistry 52:547-556
72. Sarell CJ, Syme CD, Rigby SEJ, Viles JH (2009) Copper(II) Binding to Amyloid-beta Fibrils of Alzheimer's Disease Reveals a Picomolar Affinity: Stoichiometry and Coordination Geometry Are Independent of A beta Oligomeric Form. Biochemistry 48:4388-4402
73. Bush AI, Tanzi RE (2008) Therapeutics for Alzheimer's disease based on the Metal Hypothesis. Neurotherapeutics 5:421-432
74. Crouch PJ, White AR, Bush AI (2007) The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease. FEBS J 274:3775-3783
75. Jiang D, Men L, Wang J, Zhang Y, Chickenyen S, Wang Y, Zhou F (2007) Redox reactions of copper complexes formed with different beta-amyloid peptides and their neuropathalogical relevance. Biochemistry 46:9270-9282
76. Raffa DF, Rickard GA, Rauk A (2007) Ab initio modelling of the structure and redox behaviour of copper(I) bound to a His-His model peptide: relevance to the beta-amyloid peptide of Alzheimer's disease. J Biol Inorg Chem 12:147-164
77. Demuro A, Mina E, Kayed R, Milton SC, Parker I, Glabe CG (2005) Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280:17294-17300
78. Kayed R, Sokolov Y, Edmonds B, McIntire TM, Milton SC, Hall JE, Glabe CG (2004) Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J Biol Chem 279:46363-46366
79. Selkoe DJ (2008) Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res 192:106-113
80. Vilasi S, Sarcina R, Maritato R, De Simone A, Irace G, Sirangelo I (2011) Heparin induces harmless fibril formation in amyloidogenic W7FW14F apomyoglobin and amyloid aggregation in wild-type protein in vitro. PloS One. doi: 10.1371/journal.pone.0022076
81. Millet P, Lages CS, Haik S, Nowak E, Allemand I, Granotier C, Boussin FD (2005) Amyloid-beta peptide triggers FAS-independent apoptosis and differentiation of neural progenitor cells. Neurobiol Dis 19:57-65
82. Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK (2008) Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem 283:9089-9100
83. Mattson MP, Gleichmann M, Cheng A (2008) Mitochondria in Neuroplasticity and Neurological Disorders. Neuron 60:748-766
84. Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD (2009) Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 106:14670-14675
85. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140:918-934
86. Arispe N (2004) Architecture of the Alzheimer's a beta p ion channel pore. J Membr Biol 197:33-48
87. Arispe N, Diaz JC, Simakova O (2007) A beta ion channels. Prospects for treating Alzheimer's disease with a beta channel blockers. Biochim Biophys Acta 1768:1952-1965
88. Kagan BL, Azimov R, Azimova R (2004) Amyloid peptide channels. J Membr Biol 202:1-10
89. Bartolini M, Naldi M, Fiori J, Valle F, Biscarini F, Nicolau DV, Andrisano V (2011) Kinetic characterization of amyloid-beta 1-42 aggregation with a multimethodological approach. Anal Biochem 414:215-225
90. Rahimi F, Shanmugam A, Bitan G (2008) Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disorders. Curr Alzheimer Res 5:319-341
91. Gregoire S, Irwin J, Kwon I (2012) Techniques for monitoring protein misfolding and aggregation in vitro and in living cells. Korean J Chem Eng 29:693-702
92. Bulheller BM, Rodger A, Hirst JD (2007) Circular and linear dichroism of proteins. Physica A 9:2020-2035
93. Schweitzer-Stenner R, Measey T, Kakalis L, Jordan F, Pizzanelli S, Forte C, Griebenow K (2007) Conformations of alanine-based peptides in water probed by FTIR, Raman, vibrational circular dichroism, electronic circular dichroism, and NMR spectroscopy. Biochemistry 46:1587-1596
94. Woody RW (2009) Circular Dichroism Spectrum of Peptides in the Poly(Pro)II Conformation. J Am Chem Soc 131:8234-8245
95. Nakanishi K, Berova N, Woody RW (1995) Circular dichroism, principles and applications. Wiley VCH, Cambridge
96. Johnson WC (1985) Circular-dichroism and its empirical application to bio-polymers. Methods Biochem Anal 31:61-163
97. Greenfield NJ (2006) Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc 1:2876-2890
98. Boren K, Andersson P, Larsson M, Carlsson U (1999) Characterization of a molten globule state of bovine carbonic anhydrase - III: Loss of asymmetrical environment of the aromatic residues has a profound effect on both the near- and far-UV CD spectrum. BBA-Protein Struct M 1430:111-118
99. Wallace BA, Janes RW (2001) Synchrotron radiation circular dichroism spectroscopy of proteins: secondary structure, fold recognition and structural genomics. Curr Opin Chem Biol 5:567-571
100. Seibt J, Dehm V, Wuerthner F, Engel V (2008) Circular dichroism spectroscopy of small molecular aggregates: Dynamical features and size effects. J Chem Phys 128:204303
101. Mandal PK, Pettegrew JW (2004) Alzheimer's disease: Soluble oligomeric A beta(1-40) peptide in membrane mimic environment from solution NMR and circular dichroism studies. Neurochem Res 29:2267-2272
102. Bartolini M, Bertucci C, Bolognesi ML, Cavalli A, Melchiorre C, Andrisano V (2007) Insight into the kinetic of amyloid beta(1-42) peptide self-aggregation: Elucidation of inhibitors' mechanism of action. Chembiochem 8:2152-2161
103. Cao P, Meng F, Abedini A, Raleigh DP (2010) The ability of rodent islet amyloid polypeptide to inhibit amyloid formation by human islet amyloid polypeptide has important implications for the mechanism of amyloid formation and the design of inhibitors. Biochemistry 49:872-881
104. Bertucci C, Pistolozzi M, De Simone A (2010) Circular dichroism in drug discovery and development: an abridged review. Anal Bioanal Chem 398:155-166
105. Adochitei A, Drochioiu G (2011) Rapid characterization of peptide secondary structure by FT-IR spectroscopy. Rev Roum Chim 56:783-791
106. Byler DM, Susi H (1986) Examination of the secondary structure of proteins by deconvolved FTIR spectra. Biopolymers 25:469-487
107. DeFlores LP, Ganim Z, Nicodemus RA, Tokmakoff A (2009) Amide I '-II' 2D IR spectroscopy provides enhanced protein secondary structural sensitivity. J Am Chem Soc 131:3385-3391
108. Emmambux MN, Taylor JRN (2009) Properties of heat-treated sorghum and maize meal and their prolamin proteins. J Agric Food Chem 57:1045-1050
109. Jung C (2000) Insight into protein structure and protein-ligand recognition by Fourier transform infrared spectroscopy. J Mol Recognit 13:325-351
110. Choi YY, Jang JH, Park MH, Choi BG, Chi B, Jeong B (2010) Block length affects secondary structure, nanoassembly and thermosensitivity of poly(ethylene glycol)-poly(L-alanine) block copolymers. J Mater Chem 20:3416-3421
111. Markossian KA, Yudin IK, Kurganov BI (2009) Mechanism of suppression of protein aggregation by alpha-crystallin. Int J Mol Sci 10:1314-1345
112. Pryor NE, Moss MA, Hestekin CN (2012) Unraveling the early events of amyloid-beta protein (a beta) aggregation: Techniques for the determination of a beta aggregate size. Int J Mol Sci 13:3038-3072
113. Hawe A, Sutter M, Jiskoot W (2008) Extrinsic fluorescent dyes as tools for protein characterization. Pharm Res 25:1487-1499
114. Maezawa I, Hong HS, Liu R, Wu CY, Cheng RH, Kung MP, Kung HF, Lam KS, Oddo S, LaFerla FM, Jin LW (2008) Congo red and thioflavin-T analogs detect A beta oligomers. J Neurochem 104:457-468
115. Biancalana M, Koide S (2010) Molecular mechanism of thioflavin-T binding to amyloid fibrils. Biochim Biophys Acta 1804:1405-1412
116. Biancalana M, Makabe K, Koide A, Koide S (2009) Molecular mechanism of thioflavin-T binding to the surface of beta-rich peptide self-assemblies. J Mol Biol 385:1052-1063
117. Wolfe LS, Calabrese MF, Nath A, Blaho DV, Miranker AD, Xiong Y (2010) Protein-induced photophysical changes to the amyloid indicator dye thioflavin T. Proc Natl Acad Sci USA 107:16863-16868
118. Groenning M (2010) Binding mode of thioflavin T and other molecular probes in the context of amyloid fibrils-current status. J Chem Biol 3:1-18
119. Stsiapura VI, Maskevich AA, Kuzmitsky VA, Turoverov KK, Kuznetsova IM (2007) Computational study of thioflavin T torsional relaxation in the excited state. J Phys Chem A 111:4829-4835
120. LeVine H (1999) Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol 309:274-284
121. Nilsson MR (2004) Techniques to study amyloid fibril formation in vitro. Methods 34:151-160
122. Klunk WE, Pettegrew JW, Abraham DJ (1989) Quantitative evaluation of Congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. J Histochem Cytochem 37:1273-1281
123. Klunk WE, Pettegrew JW, Abraham DJ (1989) 2 simple methods for quantifying low-affinity dye substrate binding. J Histochem Cytochem 37:1293-1297
124. Elhaddaoui A, Pigorsch E, Delacourte A, Turrell S (1995) Competition of Congo red and thioflavin S binding to amyloid sites in Alzheimer's diseased tissue. Biospectroscopy 1:351-356
125. Elhaddaoui A, Pigorsch E, Delacourte A, Turrell S (1995) Spectroscopic investigations of synthetic beta-amyloid peptides of Alzheimers disease. J Mol Struct 347:363-369
126. Seki T, Takahashi H, Yamamoto K, Ogawa K, Onji T, Adachi N, Tanaka S, Hide I, Saito N, Sakai N (2010) Congo Red, an amyloid-inhibiting compound, alleviates various types of cellular dysfunction triggered by mutant protein kinase C gamma that causes spinocerebellar Ataxia Type 14 (SCA14) by inhibiting oligomerization and aggregation. J Pharmacol Sci 114:206-216
127. Lendel C, Bolognesi B, Wahlstrom A, Dobson CM, Graslund A (2010) Detergent-like interaction of Congo red with the amyloid beta peptide. Biochemistry 49:1358-1360
128. Yanamandra K, Alexeyev O, Zamotin V, Srivastava V, Shchukarev A, Brorsson AC, Tartaglia GG, Vogl T, Kayed R, Wingsle G, Olsson J, Dobson CM, Bergh A, Elgh F, Morozova-Roche LA (2009) Amyloid formation by the pro-inflammatory S100A8/A9 proteins in the ageing prostate. PloS One. doi: 10.1371/journal.pone. 0005562
129. Wong HE, Qi W, Choi HM, Fernandez EJ, Kwon I (2011) A safe, blood-brain barrier permeable triphenylmethane dye inhibits amyloid-beta neurotoxicity by generating nontoxic aggregates. ACS Chem Neurosci 2:645-657
130. Harris JR (2002) In vitro fibrillogenesis of the amyloid beta(1-42) peptide: cholesterol potentiation and aspirin inhibition. Micron 33:609-626
131. Rocha S, Thueneman AF, MdC P, Coelho M, Moehwald H, Brezesinski G (2008) Influence of fluorinated and hydrogenated nanoparticles on the structure and fibrillogenesis of amyloid beta-peptide. Biophys Chem 137:35-42
132. Krysmann MJ, Castelletto V, Kelarakis A, Hamley IW, Hule RA, Pochan DJ (2008) Self-assembly and hydrogelation of an amyloid peptide fragment. Biochemistry 47:4597-4605
133. Sen A, Baxa U, Simon MN, Wall JS, Sabate R, Saupe SJ, Steven AC (2007) Mass analysis by scanning transmission electron microscopy and electron diffraction validate predictions of stacked beta-solenoid model of HET-s prion fibrils. J Biol Chem 282:5545-5550
134. Sachse C, Fändrich M, Grigorieff N (2008) Paired β-sheet structure of an Aβ(1-40) amyloid fibril revealed by electron microscopy. Proc Natl Acad Sci USA 105:7462-7466
135. Chen B, Thurber KR, Shewmaker F, Wickner RB, Tycko R (2009) Measurement of amyloid fibril mass-per-length by tilted-beam transmission electron microscopy. Proc Natl Acad Sci USA 106:14339-14344
136. Dong M, Hovgaard MB, Mamdouh W, Xu S, Otzen DE, Besenbacher F (2008) AFM-based force spectroscopy measurements of mature amyloid fibrils of the peptide glucagon. Nanotechnology. doi: 10.1088/0957-4484/19/38/384013
137. Yang J, Tamm LK, Somlyo AP, Shao Z (1993) Promises and problems of biological atomic-force microscopy. J Microsc Oxford 171:183-198
138. Blackley HKL, Sanders GHW, Davies MC, Roberts CJ, Tendler SJB, Wilkinson MJ (2000) In-situ atomic force microscopy study of beta-amyloid fibrillization. J Mol Biol 298:833-840
139. McPherson A, Malkin AJ, Kuznetsov YG (2000) Atomic force microscopy in the study of macromolecular crystal growth. Annu Rev Biophys Biomol Struct 29:361-410
140. Tatford OC, Gomme PT, Bertolini J (2004) Analytical techniques for the evaluation of liquid protein therapeutics. Biotechnol Appl Biochem 40:67-81
141. Palecek E, Ostatna V, Masarik M, Bertoncini CW, Jovin TM (2008) Changes in interfacial properties of alpha-synuclein preceding its aggregation. Analyst 133:76-84
142. Binolfi A, Rasia RM, Bertoncini CW, Ceolin M, Zweckstetter M, Griesinger C, Jovin TM, Fernandez CO (2006) Interaction of alpha-synuclein with divalent metal ions reveals key differences: A link between structure, binding specificity and fibrillation enhancement. J Am Chem Soc 128:9893-9901
143. Lee J, Culyba EK, Powers ET, Kelly JW (2011) Amyloid-beta forms fibrils by nucleated conformational conversion of oligomers. Nature Chemical Biology 7:602-609
144. Sandberg A, Luheshi LM, Sollvander S, de Barros TP, Macao B, Knowles TPJ, Biverstal H, Lendel C, Ekholm-Petterson F, Dubnovitsky A, Lannfelt L, Dobson CM, Hard T (2010) Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering. Proc Natl Acad Sci USA 107:15595-15600
145. Borsarelli CD, Falomir-Lockhart LJ, Ostatna V, Fauerbach JA, Hsiao HH, Urlaub H, Palecek E, Jares-Erijman EA, Jovin TM (2012) Biophysical properties and cellular toxicity of covalent crosslinked oligomers of alpha-synuclein formed by photoinduced side-chain tyrosyl radicals. Free Radical Biol Med 53:1004-1015
146. Cai XH, Rivas G, Farias PAM, Shiraishi H, Wang J, Palecek E (1996) Potentiometric stripping analysis of bioactive peptides at carbon electrodes down to subnanomolar concentrations. Anal Chim Acta 332:49-57
147. Masarik M, Stobiecka A, Kizek R, Jelen F, Pechan Z, Hoyer W, Jovin TM, Subramaniam V, Palecek E (2004) Sensitive electrochemical detection of native and aggregated alpha-synuclein protein involved in Parkinson's disease. Electroanalysis 16:1172-1181
148. Ostatna V, Cernocka H, Kurzatkowska K, Palecek E (2012) Native and denatured forms of proteins can be discriminated at edge plane carbon electrodes. Anal Chim Acta 735:31-36
149. Palecek E, Jelen F, Teijeiro C, Fucik V, Jovin TM (1993) Biopolymer-modified electrodes in the voltammetric determination of nucleic acids and proteins at the submicrogram level. Anal Chim Acta 273:175-186
150. Svarovsky MJ, Palecek SP (2005) Disruption of LRGI inhibits mother-daughter separation in Saccharomyces cerevisiae. Yeast 22:1117-1132
151. Wang HY, Ying YL, Li Y, Kraatz HB, Long Y-T (2011) Nanopore analysis of beta-amyloid peptide aggregation transition induced by small molecules. Anal Chem 83:1746-1752
152. Chan T, Chow AM, Cheng XR, Tang DWF, Brown IR, Kerman K (2012) Oxidative stress effect of dopamine on α-synuclein: Electroanalysis of solvent interactions. ACS Chem Neurosci 3:569-574
153. Chan T, Chow AM, Tang DWF, Li Q, Wang X, Brown IR, Kerman K (2010) Interaction of baicalein and copper with alpha-synuclein: Electrochemical approach to Parkinson's disease. J Electroanal Chem 648:151-155
154. Chikae M, Fukuda T, Kerman K, Idegami K, Miura Y, Tamiya E (2008) Amyloid-beta detection with saccharide immobilized gold nanoparticle on carbon electrode. Bioelectrochemistry 74:118-123
155. Hung VWS, Masoom H, Kerman K (2012) Label-free electrochemical detection of amyloid beta aggregation in the presence of iron, copper and zinc. J Electroanal Chem 681:89-95
156. Veloso AJ, Chan T, Hung VWS, Lam L, Kerman K (2011) Insight into amyloid formation using Congo red as the electrochemical probe. Electroanalysis 23:2753-2756
157. Veloso AJ, Dhar D, Chow AM, Zhang B, Tang DWF, Ganesh HVS, Mikhaylichenko S, Brown IR, Kerman K (2012) Sym-triazines for directed multi-target modulation of cholinesterases and amyloid-beta in Alzheimer's disease. ACS Chem Neurosci
158. Veloso AJ, Hung VWS, Sindhu G, Constantinof A, Kerman K (2009) Electrochemical oxidation of benzothiazole dyes for monitoring amyloid formation related to Alzheimer's disease. Anal Chem 81:9410-9415
159. Veloso AJ, Kerman K (2012) Modulation of fibril formation by a beta-sheet breaker peptide ligand: An electrochemical approach. Bioelectrochemistry 84:49-52
160. Vestergaard M, Kerman K (2009) Analytical Tools for Detecting Amyloid Beta Oligomerisation and Assembly. Curr Pharm Anal 5:229-245
161. Vestergaard M, Kerman K, Saito M, Nagatani N, Takamura Y, Tamiya E (2005) A rapid label-free electrochemical detection and kinetic study of Alzheimer's amyloid beta aggregation. J Am Chem Soc 127:11892-11893
162. de la Fuente E, Adura C, Kogan MJ, Bollo S (2012) Carbon nanotubes electrochemistry allows the in situ evaluation of the effect of beta-sheet breakers on the aggregation process of ss-amyloid. Electroanalysis 24:938-944
163. Protopapa E, Maude S, Aggeli A, Nelson A (2009) Interaction of self-assembling beta-sheet peptides with phospholipid monolayers: The role of aggregation state, polarity, charge and applied field. Langmuir 25:3289-3296
164. Grabowska I, Radecka H, Burza A, Radecki J, Kaliszan M, Kaliszan R (2010) Association constants of pyridine and piperidine alkaloids to amyloid beta peptide determined by electrochemical impedance spectroscopy. Curr Alzheimer Res 7:165-172
165. Wang J (2006) Controlled-potential techniques. In: Analytical electrochemistry. John Wiley & Sons, New York
166. Takata M, Kerman K, Nagatani N, Konaka H, Namiki M, Tamiya E (2006) Label-free bioelectronic immunoassay for the detection of human telomerase reverse transcriptase in urine. J Electroanal Chem 596:109-116
167. Kerman K, Morita Y, Takamura Y, Tamiya E (2005) Escherichia coli single-strand binding protein-DNA interactions on carbon nanotube-modified electrodes from a label-free electrochemical hybridization sensor. Anal Bioanal Chem 381:1114-1121
168. Kerman K, Nagatani N, Chikae M, Yuhi T, Takamura Y, Tamiya E (2006) Label-free electrochemical immunoassay for the detection of human chorionic gonadotropin hormone. Anal Chem 78:5612-5616
169. Havran L, Billova S, Palecek E (2004) Electroactivity of avidin and streptavidin. Avidin signals at mercury and carbon electrodes respond to biotin binding. Electroanalysis 16:1139-1148
170. Brabec V (1980) Electrochemical oxidation of nucleic-acids and proteins at graphite electrode - Qualitative aspects. Bioelectrochem Bioenerg 7:69-82
171. Brabec V, Schindlerová I (1981) Electrochemical behaviour of proteins at graphite electrodes: Part III. The effect of protein adsorption. Bioelectrochem Bioenerg 8:451-458
172. Reynaud JA, Malfoy B, Bere A (1980) The electrochemical oxidation of 3 proteins - RNAase-A, bovine serum-albumin and concanavalin-A at solid electrodes. Bioelectrochem Bioenerg 7:595-606
173. Reynolds NC, Kissela BM, Fleming LH (1995) The voltammetry of neuropeptides containing L-tyrosine. Electroanalysis 7:1177-1181
174. Enache TA, Oliveira-Brett AM (2011) Phenol and para-substituted phenols electrochemical oxidation pathways. J Electroanal Chem 655:9-16
175. Costanzo F, Sulpizi M, Della Valle RG, Sprik M (2011) The oxidation of tyrosine and tryptophan studied by a molecular dynamics normal hydrogen electrode. J Chem Phys 134
176. Enache TA, Oliveira-Brett AM (2011) Boron doped diamond and glassy carbon electrodes comparative study of the oxidation behaviour of cysteine and methionine. Bioelectrochemistry 81:46-52
177. Zhou WB, Freed CR (2004) Tyrosine-to-cysteine modification of human alpha-synuclein enhances protein aggregation and cellular toxicity. J Biol Chem 279:10128-10135
178. Ahmed M, Davis J, Aucoin D, Sato T, Ahuja S, Aimoto S, Elliott JI, Van Nostrand WE, Smith SO (2010) Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils. Nat Struct Mol Biol 17:561-U556
179. Geng J, Yu H, Ren J, Qu X (2008) Rapid label-free detection of metal-induced Alzheimer's amyloid beta peptide aggregation by electrochemical method. Electrochem Commun 10:1797-1800
180. Prabhulkar S, Piatyszek R, Cirrito JR, Wu ZZ, Li CZ (2012) Microbiosensor for Alzheimer's disease diagnostics: detection of amyloid beta biomarkers. J Neurochem 122:374-381
181. Palecek E, Scheller F, Wang J (2006) Electrochemistry of Nucleic Acids and Proteins: Towards Electrochemical Sensors for Genomics and Proteomics. Elsevier Science
182. Mairanovskii S (1968) Catalytic and kinetic waves in polarography. Plenum Press, New York
183. Tomschik M, Havran L, Fojta M, Palecek E (1998) Constant current chronopotentiometric stripping analysis of bioactive peptides at mercury and carbon electrodes. Electroanalysis 10:403-409
184. Honeychurch MJ, Ridd MJ (1996) Derivative chronopotentiometric stripping analysis of insulin. Electroanalysis 8:49-54
185. Huska D, Adam V, Zitka O, Kukacka J, Prusa R, Kizek R (2009) Chronopotentiometric stripping analysis of gelatinase B, collagen and their interaction. Electroanalysis 21:536-541
186. Kizek R, Trnkova L, Palecek E (2001) Determination of metallothionein at the femtomole level by constant current stripping chronopotentiometry. Anal Chem 73:4801-4807
187. Tomschik M, Havran L, Palecek E, Heyrovsky M (2000) The "presodium" catalysis of electroreduction of hydrogen ions on mercury electrodes by metallothionein. An investigation by constant current derivative stripping chronopotentiometry. Electroanalysis 12:274-279
188. Ostatna V, Cernocka H, Palecek E (2010) Protein structure-sensitive electrocatalysis at dithiothreitol-modified electrodes. J Am Chem Soc 132:9408-9413
189. Palecek E, Ostatna V (2009) Potential-dependent surface denaturation of BSA in acid media. Analyst 134:2076-2080
190. Palecek E, Ostatna V (2009) Ionic strength-dependent structural transition of proteins at electrode surfaces. Chem Commun 1685-1687
191. Juskova P, Ostatna V, Palecek E, Foret F (2010) Fabrication and characterization of solid mercury amalgam electrodes for protein analysis. Anal Chem 82:2690-2695
192. Veloso AJ, Hung VWS, Cheng XR, Kerman K (2012) Electroanalysis of amyloid-β aggregation kinetics using sym-triazine β-sheet inhibitors. Electroanalysis 24:1847-1851
193. Summerlot D, Kumar A, Das S, Goldstein L, Seal S, Diaz D, Cho HJ (2011) Nanoporous Gold Electrode for Electrochemical Sensors in Biological Environment. In: Kaltsas G, Tsamis C (eds) Eurosensors Xxv. Elsevier, Amsterdam
194. Feitelso J (1969) Environmental effects on fluorescence of tyrosine and its homologues. Photochem Photobiol 9:401-410
195. Guzow K, Szabelski M, Rzeska A, Karolczak J, Sulowska H, Wiczk W (2002) Photophysical properties of tyrosine at low pH range. Chem Phys Lett 362:519-526
196. Zhang L, Yagnik G, Peng Y, Wang J, Xu HH, Hao Y, Liu Y-N, Zhou F (2013) Kinetic studies of inhibition of the amyloid beta (1-42) aggregation using a ferrocene-tagged beta-sheet breaker peptide. Anal Biochem 434:292-299
197. Partovi-Nia R, Beheshti S, Qin Z, Mandal HS, Long Y-T, Girault HH, Kraatz H-B (2012) Study of amyloid beta-peptide (A beta 12-28-Cys) interactions with Congo red and beta-sheet breaker peptides using electrochemical impedance spectroscopy. Langmuir 28:6377-6385
198. Protopapa E, Ringstad L, Aggeli A, Nelson A (2010) Interaction of self-assembling beta-sheet peptides with phospholipid monolayers: The effect of serine, threonine, glutamine and asparagine amino acid side chains. Electrochim Acta 55:3368-3375
199. Krazinski BE, Radecki J, Radecka H (2011) Surface plasmon resonance based biosensors for exploring the influence of alkaloids on aggregation of amyloid-beta peptide. Sensors 11:4030-4042
200. Orazem ME, Tribollet B (2008) Electrochemical impedance spectroscopy. John Wiley & Sons, Inc., Hoboken
201. K'Owino IO, Sadik OA (2005) Impedance spectroscopy: A powerful tool for rapid biomolecular screening and cell culture monitoring. Electroanalysis 17:2101-2113
202. Lvovich VF (2012) Fundamentals of electrochemical impedance spectroscopy. In: Impedance Spectroscopy. John Wiley & Sons, Inc, New York
203. Szymanska I, Radecka H, Radecki J, Kaliszan R (2007) Electrochemical impedance spectroscopy for study of amyloid beta-peptide interactions with (-) nicotine ditartrate and (-) cotinine. Biosens Bioelectron 22:1955-1960
204. Ishii J, Chikae M, Toyoshima M, Ukita Y, Miura Y, Takamura Y (2011) Electrochemical assay for saccharide-protein interactions using glycopolymer-modified gold nanoparticles. Electrochem Commun 13:830-833
205. Zhao J, Gao T, Yan Y, Chen G, Li G (2013) Probing into the interaction of β-amyloid peptides with bilayer lipid membrane by electrochemical techniques. Electrochem Commun 30:26-28